image
KORU Medical Systems, Inc. KRMD
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 2.14
-6.14 %
$ 98.3 M
Market Cap
-16.46
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KRMD stock under the worst case scenario is HIDDEN Compared to the current market price of 2.14 USD, KORU Medical Systems, Inc. is HIDDEN

KRMD Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KRMD stock under the base case scenario is HIDDEN Compared to the current market price of 2.14 USD, KORU Medical Systems, Inc. is HIDDEN

KRMD Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KRMD stock under the best case scenario is HIDDEN Compared to the current market price of 2.14 USD, KORU Medical Systems, Inc. is HIDDEN

KRMD Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart KRMD

image
1M -39%
6M -27%
1Y 1%
3Y -31%
5Y -408%
All
$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
33.6 M REVENUE
17.98%
Growth Rates
1Year 17.98%
3Years 12.72%
5Years 7.75%
7Years 11.23%
10Years 11.58%
-5.56 M OPERATING INCOME
45.88%
Growth Rates
1Year 45.88%
3Years 7.53%
5Years -60.01%
7Years -24.91%
10Years -19.31%
-6.07 M NET INCOME
55.85%
Growth Rates
1Year 55.85%
3Years -9.96%
5Years -63.68%
7Years -30.90%
10Years -24.65%
-320 K OPERATING CASH FLOW
93.47%
Growth Rates
1Year 93.47%
3Years 58.01%
5Years -14.84%
7Years -4.44%
10Years -3.33%
-1.33 M INVESTING CASH FLOW
-63.64%
Growth Rates
1Year -63.64%
3Years -53.83%
5Years -15.07%
7Years -29.41%
10Years -5.99%
-249 K FINANCING CASH FLOW
-13.55%
Growth Rates
1Year -13.55%
3Years -2.97%
5Years -8.39%
7Years -44.00%
10Years -7.17%
8.84 M REVENUE
8.05%
Growth Rates
1Year 17.98%
3Years 12.72%
5Years 7.75%
7Years 11.23%
10Years 11.58%
-1.59 M OPERATING INCOME
6.68%
Growth Rates
1Year 45.88%
3Years 7.53%
5Years -60.01%
7Years -24.91%
10Years -19.31%
-1.56 M NET INCOME
1.24%
Growth Rates
1Year 55.85%
3Years -9.96%
5Years -63.68%
7Years -30.90%
10Years -24.65%
940 K OPERATING CASH FLOW
201.70%
Growth Rates
1Year 93.47%
3Years 58.01%
5Years -14.84%
7Years -4.44%
10Years -3.33%
50.7 K INVESTING CASH FLOW
104.60%
Growth Rates
1Year -63.64%
3Years -53.83%
5Years -15.07%
7Years -29.41%
10Years -5.99%
-216 K FINANCING CASH FLOW
-57.61%
Growth Rates
1Year -13.55%
3Years -2.97%
5Years -8.39%
7Years -44.00%
10Years -7.17%
Balance Sheet KORU Medical Systems, Inc.
image
Current Assets 19.1 M
Cash & Short-Term Investments 9.58 M
Receivables 6 M
Other Current Assets 3.55 M
Non-Current Assets 8.09 M
Long-Term Investments 0
PP&E 7.26 M
Other Non-Current Assets 829 K
35.20 %22.04 %13.06 %26.66 %3.05 %Total Assets$27.2m
Current Liabilities 7.2 M
Accounts Payable 1.65 M
Short-Term Debt 516 K
Other Current Liabilities 5.04 M
Non-Current Liabilities 3.2 M
Long-Term Debt 3.2 M
Other Non-Current Liabilities 0
15.86 %4.96 %48.40 %30.78 %Total Liabilities$10.4m
EFFICIENCY
Earnings Waterfall KORU Medical Systems, Inc.
image
Revenue 33.6 M
Cost Of Revenue 12.3 M
Gross Profit 21.3 M
Operating Expenses 26.9 M
Operating Income -5.56 M
Other Expenses 509 K
Net Income -6.07 M
35m35m30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)(10m)(10m)34m(12m)21m(27m)(6m)(509k)(6m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
63.40% GROSS MARGIN
63.40%
Averages
1Year 63.40%
3Years 59.03%
5Years 59.50%
7Years 60.56%
10Years 60.68%
-16.52% OPERATING MARGIN
-16.52%
Averages
1Year -16.52%
3Years -30.39%
5Years -25.26%
7Years -16.72%
10Years -10.41%
-18.03% NET MARGIN
-18.03%
Averages
1Year -18.03%
3Years -32.42%
5Years -24.34%
7Years -16.29%
10Years -10.52%
-36.08% ROE
-36.08%
Averages
1Year -36.08%
3Years -43.75%
5Years -29.42%
7Years -18.84%
10Years -11.48%
-22.29% ROA
-22.29%
Averages
1Year -22.29%
3Years -30.34%
5Years -21.02%
7Years -13.20%
10Years -7.79%
-27.06% ROIC
-27.06%
Averages
1Year -27.06%
3Years -36.47%
5Years -25.30%
7Years -16.06%
10Years -9.54%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis KORU Medical Systems, Inc.
image
2m2m1m1m00(1m)(1m)(2m)(2m)(3m)(3m)(4m)(4m)(5m)(5m)(6m)(6m)(7m)(7m)(8m)(8m)(9m)(9m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -6.07 M
Depreciation & Amortization 888 K
Capital Expenditures -1.3 M
Stock-Based Compensation 2.62 M
Change in Working Capital 1.97 M
Others 2.56 M
Free Cash Flow -1.62 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets KORU Medical Systems, Inc.
image
Wall Street analysts predict an average 1-year price target for KRMD of $3.42 , with forecasts ranging from a low of $3 to a high of $4.5 .
KRMD Lowest Price Target Wall Street Target
3 USD 40.19%
KRMD Average Price Target Wall Street Target
3.42 USD 59.66%
KRMD Highest Price Target Wall Street Target
4.5 USD 110.28%
Price
Max Price Target
Min Price Target
Average Price Target
55554444333322May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 6
6. Ownership
Insider Ownership KORU Medical Systems, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Louisa Smith - Investor Relations Linda Tharby - Chief Executive Officer and President Tom Adams - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig Hallum Capital Group Frank Takkinen - Lake Street Capital Markets Jason Bednar - Piper Sandler Anderson Shack - B. Riley Securities Michaela Smith - Canaccord Operator Greetings. seekingalpha.com - 1 month ago
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that. businesswire.com - 1 month ago
KORU Medical Systems Has A Long Runway KORU Medical Systems' stock has surged 60% since November, driven by the success of its FREEDOM System for subcutaneous immunoglobulin delivery. The SCIg market is growing rapidly, with KORU outperforming competitors by capturing market share and benefiting from trends like prefilled syringes. Strong international growth, new therapies, and product innovations are key drivers, with significant revenue from recurring patients and promising future launches. seekingalpha.com - 2 months ago
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunogl. businesswire.com - 2 months ago
KORU Medical Systems Inc. (KRMD) is a Great Momentum Stock: Should You Buy? Does KORU Medical Systems Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out. zacks.com - 2 months ago
KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in Piper Sandler's 36th Annual Healthcare Conference on December 5, 2024. KORU Medical's management is scheduled to present at Piper Sandler's 36th Annual Healthcare. businesswire.com - 4 months ago
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript seekingalpha.com - 5 months ago
KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago. zacks.com - 5 months ago
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2024, and raised full year 2024 revenue, gross margin, and year-end cash guidance. Recent Highlights Third quarter 2024 net revenues of $8. businesswire.com - 5 months ago
KORU Medical Systems to Participate in Upcoming Investor Conferences MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in two upcoming Investor Conferences. KORU Medical's management team is participating at the 15th Annual Craig-Hallum Alpha Select Conference on Tuesday, Novemb. businesswire.com - 5 months ago
Impressive Turnaround At KORU Medical KORU Medical Systems is poised for growth with solid revenue increases, multiple growth drivers, and a chance to reach cash flow breakeven in Q4. The FREEDOM system, designed for at-home drug delivery, offers recurring revenue from consumables and is gaining market share in the SCIg market. International expansion and novel therapies present significant growth opportunities, with international revenue growing 46% and novel therapies progressing to Phase 3 trials. seekingalpha.com - 5 months ago
KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript seekingalpha.com - 8 months ago
8. Profile Summary

KORU Medical Systems, Inc. KRMD

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 98.3 M
Dividend Yield 0.00%
Description KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Contact 24 Carpenter Road, Chester, NY, 10918 https://www.korumedical.com
IPO Date April 5, 1994
Employees 80
Officers Mr. Thomas Adams Chief Financial Officer, Secretary & Treasurer Mr. Christopher Pazdan Chief Operating Officer Mr. Rob Cannon Vice President of Sales Ms. Linda M. Tharby President, Chief Executive Officer & Director Mr. Kenneth Miller Chief Commercial Officer